Compare Stocks

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABCN VIVO Cannabis	C$1.32 +5.6%	C$1.32	C$0.80 ▼ C$4.06	C$256.62M	N/A	1.51 million shs	310,601 shs
ATTBF Abattis Bioceuticals		$0.00	$0.00 ▼ $0.00	N/A	N/A	11,650 shs	N/A
PREV PreveCeutical Medical		$0.00	$0.00 ▼ $0.00	N/A	N/A	N/A	694,224 shs

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABCN VIVO Cannabis	0.00%	0.00%	0.00%	0.00%	0.00%
ATTBF Abattis Bioceuticals	0.00%	0.00%	0.00%	0.00%	0.00%
PREV PreveCeutical Medical	0.00%	0.00%	0.00%	0.00%	0.00%

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PREV PreveCeutical Medical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A
PREV PreveCeutical Medical	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A	N/A
PREV PreveCeutical Medical	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABCN VIVO Cannabis	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	-$0.16	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PREV PreveCeutical Medical	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A
PREV PreveCeutical Medical	N/A	N/A	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
ABCN VIVO Cannabis	N/A
ATTBF Abattis Bioceuticals	32.45%
PREV PreveCeutical Medical	N/A

Insider Ownership

Company	Insider Ownership
ABCN VIVO Cannabis	N/A
ATTBF Abattis Bioceuticals	N/A
PREV PreveCeutical Medical	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ABCN VIVO Cannabis	N/A	194.41 million	N/A	Not Optionable
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	Not Optionable
PREV PreveCeutical Medical	N/A	N/A	N/A	Not Optionable

PREV, ATTBF, ABCN, ABZA, and AHZ Headlines

Source	Headline
	PreveCeutical Medical Inc. (PRVCF) finance.yahoo.com - April 18 at 2:18 PM
	Medical Detox psychologytoday.com - March 27 at 1:47 AM
	Alleged 'primary architect' of Bridgemark consulting case settles for nearly $1M fine nsnews.com - February 23 at 10:36 PM
	PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM finance.yahoo.com - December 4 at 7:15 AM
	PreveCeutical Medical Inc. (PREV.CN) finance.yahoo.com - November 24 at 8:46 AM
	Answering All Your Questions About Medical Alert Systems forbes.com - September 12 at 8:56 AM
	PreveCeutical Engages New to the Street for Production & Broadcasting Services finance.yahoo.com - August 31 at 8:00 AM
	PreveCeutical Files Cyclic Peptides And Uses Thereof in the EU and Australia finance.yahoo.com - July 24 at 8:53 AM
	PRVCF - PreveCeutical Medical Inc. finance.yahoo.com - July 15 at 8:57 AM
	Higher Credit Scores: New Medical Debt Rules Could Give a Boost cnet.com - April 27 at 5:35 PM
	PreveCeutical Medical Inc.: PreveCeutical Initiates Non-Analgesic (Painkiller) Program, Clinical Development Program & Disclosure Committee finanznachrichten.de - March 23 at 8:08 PM
	PreveCeutical Medical Inc.: PreveCeutical - International Filing of Thermoresponsive Sol-Gels Containing Cannabinoids & Uses Thereof finanznachrichten.de - March 6 at 7:38 AM
	PreveCeutical - International Filing of Thermoresponsive Sol-Gels Containing Cannabinoids & Uses Thereof finance.yahoo.com - March 6 at 7:38 AM
	PreveCeutical - Australian Patent Granted for Disulfide Bond Containing Compounds finance.yahoo.com - January 25 at 8:32 AM
	PreveCeutical - Background IP, US Patent Granted Disulfide Bond Containing Compounds finance.yahoo.com - January 23 at 7:34 AM
	PreveCeutical Medical Inc.: PreveCeutical - Dynorphin Peptides (Painkiller) and Uses Thereof Patent Update and Officer Update finanznachrichten.de - January 17 at 8:03 AM
	PreveCeutical - Dynorphin Peptides (Painkiller) and Uses Thereof Patent Update and Officer Update finance.yahoo.com - January 17 at 8:03 AM
	Aaron Donald is in Madden’s 99 Club for 6th year in a row yahoo.com - July 24 at 6:42 PM
	PreveCeutical Medical enters into $3M credit facility seekingalpha.com - July 24 at 6:42 PM
	PreveCeutical Enters into Credit Facility Agreement finance.yahoo.com - July 22 at 6:27 PM
	PreveCeutical Medical Inc.: PreveCeutical Announces Change in Directors and Investor Awareness Services finanznachrichten.de - May 29 at 8:14 AM
	PreveCeutical Medical Inc.: Article Based on PreveCeutical's Pain Management Peptides Program Published in the British Journal of Pharmacology finanznachrichten.de - May 11 at 11:47 PM
	PreveCeutical Medical Inc (PREV) investing.com - April 4 at 7:00 PM
	Converting Cannabis Liquid To Gel Form: Is It Revolutionary For The Marijuana Industry? msn.com - February 15 at 4:50 PM

New MarketBeat Followers Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Foot Locker Builds Up Another Head of Steam; Gains Imminent
March 28, 2024 10:58 AM
View Foot Locker Builds Up Another Head of Steam; Gains Imminent
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
March 27, 2024 7:30 AM
View Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Green Gold Rush: Here's What's Driving Cannabis Stocks Higher
April 2, 2024 7:17 AM
View Green Gold Rush: Here's What's Driving Cannabis Stocks Higher
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
April 19, 2024 8:59 AM
View Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

All Headlines

Company Descriptions

VIVO Cannabis

CVE:ABCN

ABcann Global Corporation manufactures and distributes medical cannabis. The company is headquartered in Napanee, Canada.

Abattis Bioceuticals

OTCMKTS:ATTBF

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

PreveCeutical Medical

CNSX:PREV

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial